Awarded a partially refundable grant for research project: Bluespe
Tue, 31/07/2018 - 00:00
1 minAwarded a partially refundable grant for research project: Bluespe
Related
Today, Laboratorios Farmacéuticos Rovi, S.A. (“ROVI”) has announced the conclusion of the PRISMA-3 and BORIS studies, thus...
5 min
05/07/2019
The López-Belmonte family, the principal shareholders of Laboratorios Farmacéuticos Rovi, S.A. (“ROVI”), have increased their interest in...
1 min
27/05/2019
The operating revenue of Laboratorios Farmacéuticos ROVI increased by 8% to 82.2 million euros in the first quarter of 2019, mainly driven...
5 min
08/05/2019
Awarded a partially refundable grant for research project: Bluespe